Clinical Trial Update: A Study of Bitopertin (RO4917838) in Adults With Non-Transfusion-Dependent (NTD) Beta-Thalassemia [Phase 2]

View source ↗

Summary

Phase 2 trial update of Bitopertin (RO4917838) in adults with non-transfusion-dependent beta-thalassemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• Bitopertin (bitopertin)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Beta-Thalassemia | Phase 2 | Status: COMPLETED